APR 28, 2020 8:37 AM PDT

Is a multi-cancer detection blood test safe for women?

Earlier detection is essential in order to reduce deaths caused by cancer. A new study, DETECT-A (Detecting cancers Earlier Through Elective mutation-based blood Collection and Testing), has been published recently in the journal Science. Researchers conducting the study have developed a blood test called CancerSEEK that is capable of detecting eight common types of cancer with non-invasive methods. While the new blood test is not meant to replace other methods of early detection,  it is hoped that it will aid in improving detection among particular cancers that are difficult to detect, like ovarian cancer. 

The researchers caution that the study was not conducted with regulatory approval of a specific test in mind. Furthermore, they comment that larger formal trials will be imperative to determine the clinical validity and utility of CancerSEEK as a detection method. 

The study included women with no history of cancer, ages 65 to 75. Lead researcher, Anne Marie Lennon and her colleagues analyzed circulating DNA and protein biomarkers of cancer in the blood of the participating women. The researchers applied the CancerSEEK test to 1005 patients with nonmetastatic, clinically detected cancers of the ovary, liver, stomach, pancreas, esophagus, colorectum, lung, or breast and found that the tests were positive in a median of 70% of the eight cancer types.

They found that some cancers were detected by blood analysis, while others were detected by other traditional detection means, like a full-body diagnostic positron emission tomography-computed tomography (PET-CT) scan. Over the 12-month study, 96 cancers were diagnosed in total. Twenty-six of these were detected by the blood test, 24 by standard screening, and 46 by other means. They write in their study: 

“The sensitivities ranged from 69 to 98% for the detection of five cancer types (ovary, liver, stomach, pancreas, and esophagus) for which there are no screening tests available for average-risk individuals. The specificity of CancerSEEK was greater than 99%: only 7 of 812 healthy controls scored positive. In addition, CancerSEEK localized the cancer to a small number of anatomic sites in a median of 83% of the patients.”

Photo: Pixabay

Another important follow-up conclusion from the study shows that women who underwent blood test detection did not significantly change their habits in regards to receiving other forms of detection screening. According to Eureka Alert, the fact that the women in the study did not have fewer mammograms after the baseline blood test than they had in the years prior suggests that such a test “can be incorporated into routine clinical care and not discourage participants from engaging in standard-of-care screening, which the authors emphasize their approach shouldn't replace.” 

Sources: Science, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JAN 27, 2021
Cancer
Does intermittent fasting reduce the risk of postmenopausal breast cancer?
JAN 27, 2021
Does intermittent fasting reduce the risk of postmenopausal breast cancer?
New research in mouse models suggests that intermittent fasting could reduce the risk of metastasis of breast cancer tum ...
FEB 02, 2021
Immunology
Pumping the Brakes on Stomach Cancer Progression
FEB 02, 2021
Pumping the Brakes on Stomach Cancer Progression
By the time stomach cancer is diagnosed, it’s often bad news for patients. The disease often presents with relativ ...
FEB 10, 2021
Drug Discovery & Development
Genetics Affect Response to Cancer Immunotherapy
FEB 10, 2021
Genetics Affect Response to Cancer Immunotherapy
Researchers have found that genetic factors may dictate as much as 20% of the efficacy of checkpoint inhibitors, a kind ...
FEB 03, 2021
Cancer
What can cancer in sea lions teach us about ourselves?
FEB 03, 2021
What can cancer in sea lions teach us about ourselves?
New research from a 20-year long study on California sea lions shows cause for alarm for both ecologists and oncologists ...
MAR 23, 2021
Clinical & Molecular DX
AI Test Distinguishes Cancer Cells From Healthy Ones Based on Acidity Levels
MAR 23, 2021
AI Test Distinguishes Cancer Cells From Healthy Ones Based on Acidity Levels
Researchers have developed a new way of differentiating cancer cells from healthy ones—by how acidic they are. The ...
APR 10, 2021
Cancer
Administration of this immune-stimulating drug pre-surgery could help pancreatic cancer patients
APR 10, 2021
Administration of this immune-stimulating drug pre-surgery could help pancreatic cancer patients
New findings support the administration of a CD40 immune-stimulating drug to early-stage pancreatic cancer patients in a ...
Loading Comments...